FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 1,503,247	$ 1,641,139
Gross Unrealized Gains	644	159
Gross Unrealized Losses	(11,165)	(15,926)
Aggregate Fair Value	1,492,726	1,625,372
Cash and Cash Equivalents	580,074	724,531	[1]
Short-term marketable securities	572,017	567,006	[1]
Long-term marketable securities	340,635	333,835	[1]
Level 1: | Cash
Schedule of Available-for-sale Securities [Line Items]
Cash	279,268	463,248
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	279,268	463,248
Cash and Cash Equivalents	279,268	463,248
Short-term marketable securities	0	0
Long-term marketable securities	0	0
Level 2:
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,223,979	1,177,891
Gross Unrealized Gains	644	159
Gross Unrealized Losses	(11,165)	(15,926)
Aggregate Fair Value	1,213,458	1,162,124
Cash and Cash Equivalents	300,806	261,283
Short-term marketable securities	572,017	567,006
Long-term marketable securities	340,635	333,835
Level 2: | Money market instruments
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	300,806	248,933
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Aggregate Fair Value	300,806	248,933
Cash and Cash Equivalents	300,806	248,933
Short-term marketable securities	0	0
Long-term marketable securities	0	0
Level 2: | Corporate debt securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	427,594	504,984
Gross Unrealized Gains	189	34
Gross Unrealized Losses	(8,333)	(11,541)
Aggregate Fair Value	419,450	493,477
Cash and Cash Equivalents	0	1,881
Short-term marketable securities	262,700	299,153
Long-term marketable securities	156,750	192,443
Level 2: | U.S. government agency securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	410,940	48,103
Gross Unrealized Gains	411	11
Gross Unrealized Losses	(2,376)	(22)
Aggregate Fair Value	408,975	48,092
Cash and Cash Equivalents	0	10,469
Short-term marketable securities	290,059	37,623
Long-term marketable securities	118,916	0
Level 2: | Commercial paper
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	15,325	312,720
Gross Unrealized Gains	2	45
Gross Unrealized Losses	(9)	(3,771)
Aggregate Fair Value	15,318	308,994
Cash and Cash Equivalents	0	0
Short-term marketable securities	15,318	229,846
Long-term marketable securities	0	79,148
Level 2: | Asset-backed securities
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	69,314	63,151
Gross Unrealized Gains	42	69
Gross Unrealized Losses	(447)	(592)
Aggregate Fair Value	68,909	62,628
Cash and Cash Equivalents	0	0
Short-term marketable securities	3,940	384
Long-term marketable securities	$ 64,969	$ 62,244
Maximum
Schedule of Available-for-sale Securities [Line Items]
Short term marketable securities maturity period	1 year	1 year
Long term marketable securities maturity period	5 years	5 years
Minimum
Schedule of Available-for-sale Securities [Line Items]
Long term marketable securities maturity period	1 year	1 year

[1] (1)December 31, 2022 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on February 27, 2023.